Keenly-watched Covid-19 vaccine won't be expensive, developer says

A keenly-watched Covid-19 vaccine will be priced to allow as wide as possible access to it, if it proves successful, and will be made at huge scale to keep costs down and supply up, said the Oxford University professor co-leading its development.

Adrian Hill, director of Oxford's Jenner Institute, which has teamed up with the drugmaker AstraZeneca to develop the vaccine, said ensuring wide distribution and low cost...